Advertisement
Screener

CO2 ENERGY TRANSITION CORP. (NOEM) Increase (Decrease) in Accounts Payable and Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

CO2 ENERGY TRANSITION CORP. Increase (Decrease) in Accounts Payable and Accrued Liabilities

CO2 ENERGY TRANSITION CORP. (NOEM) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$87.36 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-13

  • CO2 ENERGY TRANSITION CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $59.54K.
  • CO2 ENERGY TRANSITION CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$146.90K.
  • CO2 ENERGY TRANSITION CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $44.47K, a 76.03% decline year-over-year.
  • CO2 ENERGY TRANSITION CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$17.91K, a 315.59% decline year-over-year.
  • CO2 ENERGY TRANSITION CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$155.51K, a 202.62% decline from fiscal 2024.
  • CO2 ENERGY TRANSITION CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $151.53K, a 117.56% increase from fiscal 2023.
  • CO2 ENERGY TRANSITION CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $69.65K.
Period endIncrease (Decrease) in Accounts Payable and Accrued Liabilities 3 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 6 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 9 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 12 month
2026-06-30$59.54K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$87.36K
10-Q · filed 2026-08-13
-$42.89K
derived: sum of 3 quarters · filed 2026-08-13
-$60.79K
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$146.90K
10-Q · filed 2026-05-15
-$102.43K
derived: sum of 2 quarters · filed 2026-05-15
-$120.33K
derived: sum of 3 quarters · filed 2026-05-15
-$172.24K
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$44.47K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$26.56K
derived: sum of 2 quarters · filed 2026-03-16
-$25.34K
derived: sum of 3 quarters · filed 2026-08-13
-$155.51K
10-K · filed 2026-03-16
2025-09-30-$17.91K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$69.81K
derived: sum of 2 quarters · filed 2026-08-13
-$199.98K
10-Q · filed 2025-11-13
-$14.43K
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30-$51.91K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$182.07K
10-Q · filed 2026-08-13
$3.47K
derived: sum of 3 quarters · filed 2026-08-13
$11.78K
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31-$130.17K
10-Q · filed 2026-05-15
$55.38K
derived: sum of 2 quarters · filed 2026-05-15
$63.68K
derived: sum of 3 quarters · filed 2026-05-15
$68.06K
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31$185.54K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$193.85K
derived: sum of 2 quarters · filed 2026-03-16
$198.23K
derived: sum of 3 quarters · filed 2026-03-16
$151.53K
10-K · filed 2026-03-16
2024-09-30$8.30K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$12.68K
derived: sum of 2 quarters · filed 2025-11-13
-$34.01K
10-Q · filed 2025-11-13
$10.84K
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$4.38K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
-$42.31K
10-Q · filed 2025-08-12
$2.54K
derived: sum of 3 quarters · filed 2025-08-12
2024-03-31-$46.69K
10-Q · filed 2025-05-13
-$1.84K
derived: sum of 2 quarters · filed 2025-05-13
2023-12-31$44.85K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$69.65K
10-K · filed 2025-03-31
2023-09-30$24.80K
10-Q · filed 2024-12-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aimei Health Technology Co., Ltd. (AFJK)United States$0.038B
Israel Acquisitions Corp (ISRL)United States$0.032B
Innventure, Inc. (INV)United States$0.068B-2.99
Origin Investment Corp I (ORIQ)$0.090B13.93
XFLH Capital Corp (XFLH)United States$0.139B
Aldel Financial II Inc. (ALDF)United States$0.323B